Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2023
Jul. 31, 2023
Current assets:    
Cash and cash equivalents $ 69,207 $ 82,373
Accounts receivable, net 4,181 4,808
Inventories, net 7,595 7,939
Prepaid expenses and other current assets, including $5,000 escrow at October 31, 2023 and $1,000 restricted cash at July 31, 2023 7,029 3,336
Total current assets 88,012 98,456
Property, plant, and equipment, net 13,075 13,086
Right-of-use assets 3,405 3,626
Other assets, including $5,000 escrow at July 31, 2023 726 5,745
Non-current assets of discontinued operations, net 1,090 967
Total assets 106,308 121,880
Current liabilities:    
Accounts payable – trade 1,962 3,575
Accrued liabilities 10,042 11,743
Current portion of operating lease liabilities 920 980
Other current liabilities 75 75
Convertible debentures 2,842 2,514
Current liabilities of discontinued operations, net 13,001 21,102
Total current liabilities 28,842 39,989
Operating lease liabilities, non-current 2,972 3,160
Long term debt, net 219 269
Total liabilities 32,033 43,418
Contingencies – see Note 13
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 50,489,771 at October 31, 2023 and 49,997,631 at July 31, 2023 504 499
Additional paid-in capital 345,991 344,435
Accumulated deficit (274,966) (268,350)
Accumulated other comprehensive income 2,746 1,878
Total stockholders’ equity 74,275 78,462
Total liabilities and stockholders’ equity $ 106,308 $ 121,880